INDICATION:
Montilukast is a leukotriene receptor antagonist indicated for :
prophylaxis and cronic tretment of asthma in patients 12 months of age older.
acute prevention of exercise- induced bronchoconstriction in patients 6 years of age and older.
Relief of symptoms of allergic rhinitis :seasonal allergic Rhinitis in patients 2 years of age and older .and perenial allergic rhinitis in patients 6 months of age and older.